Why U.S. odds are stacked against a promising new COVID drug
The New York Times, February 8, 2023
A study in the New England Journal of Medicine found that a single injection of a so-called interferon drug slashed by half a COVID patient’s odds of being hospitalized. The New York Times interviewed top experts not involved in the study for comments. In targeting patients’ immune responses, rather than the virus itself, those treatments potentially offered another advantage over existing treatments, reducing the chance that a variant would evolve that could resist the drug, said Vineet Menachery, an immunologist at the University of Texas Medical Branch.